CVC Capital Partners and L Catterton are among the private equity firms bidding for German premium vitamin supplement maker Orthomol, people familiar with the matter said.
Advent International, Blackstone Inc., Groupe Bruxelles Lambert NV and PAI Partners have also proceeded into the next round of bidding, according to the people. Orthomol and its founding family have been working with Houlihan Lokey Inc. and are seeking about €1 billion ($1.1 billion) in the potential sale, they said.